Myoblast-Derived Galectin 3 Impairs the Early Phases of Osteogenesis Affecting Notch and Akt Activity
Authors:
- Emanuela AmoreEAEmanuela Amore
- Vittoria CenniVCVittoria Cenni
- Manuela PiazziMPManuela Piazzi
- Michele SignoreMSMichele Signore
- Giulia OrlandiGOGiulia Orlandi
- Simona NeriSNSimona Neri
- Stefano BiressiSBStefano Biressi
- Rosario BaroneRosario Barone
- Valentina Di FeliceVFValentina Di Felice
- Matilde Y. FolloMFMatilde Y. Follo
- Jessika BertacchiniJBJessika Bertacchini
- Carla PalumboCarla Palumbo
Open Access
- 30 September 2024
- journal article
- research article
- Published by MDPI AG in Biomolecules
- Vol. 14 (10) , 1243
Abstract
Galectin-3 (Gal-3) is a pleiotropic lectin produced by most cell types, which regulates multiple cellular processes in various tissues. In bone, depending on its cellular localization, Gal-3 has a dual and opposite role. If, on the one hand, intracellular Gal-3 promotes bone formation, on the other, its circulating form affects bone remodeling, antagonizing osteoblast differentiation and increasing osteoclast activity. From an analysis of the secretome of cultured differentiating myoblasts, we interestingly found the presence of Gal-3. After that, we confirmed that Gal-3 was expressed and released in the extracellular environment from myoblast cells during their differentiation into myotubes, as well as after mechanical strain. An in vivo analysis revealed that Gal-3 was triggered by trained exercise and was specifically produced by fast muscle fibers. Speculating a role for this peptide in the muscle-to-bone cross talk, a direct co-culture in vitro system, simultaneously combining media that were obtained from differentiated myoblasts and osteoblast cells, confirmed that Gal-3 is a mediator of osteoblast differentiation. Molecular and proteomic analyses revealed that the secreted Gal-3 modulated the biochemical processes occurring in the early phases of bone formation, in particular impairing the activity of the STAT3 and PDK1/Akt signaling pathways and, at the same time, triggering that one of Notch. Circulating Gal-3 also affected the expression of the most common factors involved in osteogenetic processes, including BMP-2, -6, and -7. Intriguingly, Gal-3 was able to interfere with the ability of differentiating osteoblasts to interact with the components of the extracellular bone matrix, a crucial condition required for a proper osteoblast differentiation. All in all, our evidence lays the foundation for further studies to present this lectin as a novel myokine involved in muscle-to-bone crosstalk.Keywords
Funding Information
- FAR 2019 Interdepartmental Grant, awarded by the University of Modena and Reggio Emilia
- MIUR-PRIN 2017_RKWNJT
This publication has 35 references indexed in Scilit:
- Reverse Phase Protein Arrays in cancer stem cells2022
- Galectin-3 inhibition boosts the therapeutic efficacy of Semliki Forest virus in pediatric osteosarcomaMolecular Therapy-Oncolytics, 2022
- Muscle-derived factors influencing bone metabolismSeminars in Cell & Developmental Biology, 2022
- The therapeutic potential of galectin-3 inhibition in fibrotic diseaseThe International Journal of Biochemistry & Cell Biology, 2021
- Notch and the regulation of osteoclast differentiation and functionBone, 2020
- Galectin-3 in bone tumor microenvironment: a beacon for individual skeletal metastasis managementCancer and Metastasis Reviews, 2016
- Role of TGF-β Signaling in Coupling Bone Remodeling2016
- Galectin-3 Inhibits Osteoblast Differentiation through Notch SignalingNeoplasia, 2014
- Notch Signaling and Bone RemodelingCurrent Osteoporosis Reports, 2013
- Functional adaptation of bone to exercise and injuryJournal of Science and Medicine in Sport, 2000